These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7504142)
1. In vivo regulation of human cardiac beta-adrenoceptors by a partial agonist as compared with a full antagonist: selective differences in coupling to adenylate cyclase. Arnold IR; Mistry R; Barnett DB J Cardiovasc Pharmacol; 1993 Sep; 22(3):481-7. PubMed ID: 7504142 [TBL] [Abstract][Full Text] [Related]
2. Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase. Arnold IR; Mistry R; Barnett DB Eur J Pharmacol; 1993 May; 245(3):285-9. PubMed ID: 8392940 [TBL] [Abstract][Full Text] [Related]
3. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors. Limas CJ; Limas C J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988 [TBL] [Abstract][Full Text] [Related]
4. Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects. Lemoine H; Bilski A; Kaumann AJ J Cardiovasc Pharmacol; 1989 Jan; 13(1):105-17. PubMed ID: 2468921 [TBL] [Abstract][Full Text] [Related]
5. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells. Haynes JM Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401 [TBL] [Abstract][Full Text] [Related]
6. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. Böhm M; Mittmann C; Schwinger RH; Erdmann E Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979 [TBL] [Abstract][Full Text] [Related]
7. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors. Reithmann C; Wieland F; Jakobs KH; Werdan K Eur J Pharmacol; 1989 Nov; 170(3):243-55. PubMed ID: 2575997 [TBL] [Abstract][Full Text] [Related]
8. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine. Lemoine H; Teng KJ; Slee SJ; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions. Hattori Y; Sakuma I; Nakao Y; Kanno M J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870 [TBL] [Abstract][Full Text] [Related]
10. Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium. Brodde OE; O'Hara N; Zerkowski HR; Rohm N J Cardiovasc Pharmacol; 1984; 6(6):1184-91. PubMed ID: 6084778 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
12. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366 [TBL] [Abstract][Full Text] [Related]
13. Distinct pathways for beta-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein alpha-subunits in chicken cardiomyocytes. Reithmann C; Panzner B; Werdan K Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):530-40. PubMed ID: 1356232 [TBL] [Abstract][Full Text] [Related]
14. Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists. Brodde OE; Daul A; Michel MC Clin Physiol Biochem; 1990; 8 Suppl 2():11-7. PubMed ID: 1982757 [TBL] [Abstract][Full Text] [Related]
15. Effects of beta blocking agents on the density of beta adrenoceptors and adenylate cyclase response in human myocardium: intrinsic sympathomimetic activity favours receptor upregulation. Golf S; Hansson V Cardiovasc Res; 1986 Sep; 20(9):637-44. PubMed ID: 2878724 [TBL] [Abstract][Full Text] [Related]
16. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods. Silke B; Hanratty CG; Riddell JG J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588 [TBL] [Abstract][Full Text] [Related]
17. Cardiac beta-adrenoceptor regulation and the effects of partial agonism. Barnett DB; Lu XY Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585 [TBL] [Abstract][Full Text] [Related]
18. The functional importance of beta 1 and beta 2 adrenoceptors in the human heart. Brodde OE Am J Cardiol; 1988 Aug; 62(5):24C-29C. PubMed ID: 2900601 [TBL] [Abstract][Full Text] [Related]
19. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. Lammers JW; Müller ME; Folgering HT; van Herwaarden CL Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680 [TBL] [Abstract][Full Text] [Related]
20. [Isoproterenol, denopamine, and atenolol-induced alterations in beta-adrenergic receptor-adenylate cyclase system of rat myocardium]. Igarashi Y Hokkaido Igaku Zasshi; 1991 Sep; 66(5):647-57. PubMed ID: 1683639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]